Controversial Alzheimer's drug approval could impact other diseases

Nature, Published online: 29 June 2021; doi:10.1038/d41586-021-01763-9

Aducanumab's fast-tracking has researchers both worried and hopeful about the future of drugs for neurodegenerative diseases such as Huntington’s and Parkinson’s.

Comments

Popular posts from this blog

Photo Of The Day By Valerie Millett